ArticleInflammation2015

GlycA is a Novel Marker of Inflammation Among Non-Critically Ill Hospitalized Patients with Type 2 Diabetes.

Kathleen Dungan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.